| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030480655 |
| P356 | DOI | 10.1007/S00125-013-3032-8 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00125-013-3032-8 |
| P698 | PubMed publication ID | 23989723 |
| P50 | author | Xu-Rui Shen | Q88324943 |
| P2093 | author name string | Xing Xu | |
| Jing Chen | |||
| Lili Chen | |||
| Liang Yu | |||
| Zhiyuan Zhu | |||
| Gaihong Wang | |||
| Xingang Yao | |||
| P2860 | cites work | AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling | Q22241925 |
| The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes | Q24290189 | ||
| Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance | Q24629603 | ||
| Danthron Functions as a Retinoic X Receptor Antagonist by Stabilizing Tetramers of the Receptor | Q27665948 | ||
| (+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice | Q27677636 | ||
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase | Q28251163 | ||
| Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost | Q28305613 | ||
| Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes | Q28360697 | ||
| AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor | Q28371199 | ||
| Arctigenin efficiently enhanced sedentary mice treadmill endurance | Q28476727 | ||
| Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise | Q28581480 | ||
| Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists | Q28609829 | ||
| AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism | Q29617261 | ||
| Mechanisms for insulin resistance: common threads and missing links | Q29620447 | ||
| STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase | Q31040218 | ||
| Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions. | Q31625867 | ||
| Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice | Q33716781 | ||
| Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes | Q33918445 | ||
| Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists | Q34011043 | ||
| New drug targets for type 2 diabetes and the metabolic syndrome | Q34105009 | ||
| Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation | Q34416242 | ||
| Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review | Q34568687 | ||
| New uses for old drugs | Q34661227 | ||
| Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis | Q34686103 | ||
| AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model | Q35024638 | ||
| The central role of perilipin a in lipid metabolism and adipocyte lipolysis | Q35951062 | ||
| Transcriptional control of adipocyte formation | Q35962266 | ||
| The many faces of PPARgamma | Q36344625 | ||
| Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency | Q37175466 | ||
| AMPK: a metabolic gauge regulating whole-body energy homeostasis | Q37314854 | ||
| AMPK: an emerging drug target for diabetes and the metabolic syndrome | Q37471010 | ||
| Modulation of RXR function through ligand design | Q37868350 | ||
| Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice. | Q38325827 | ||
| T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities | Q40747044 | ||
| Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. | Q41328950 | ||
| Compound C inhibits clonal expansion of preadipocytes by increasing p21 level irrespectively of AMPK inhibition | Q42440658 | ||
| Different molecular mechanisms of vitamin D(3) receptor antagonists | Q43608480 | ||
| Side-effects and risk profile of latanoprost 0.005% (Xalatan) | Q44130220 | ||
| Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. | Q44477314 | ||
| Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states | Q46271630 | ||
| Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study | Q46458758 | ||
| The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. | Q52865510 | ||
| Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. | Q53768403 | ||
| Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost | Q85002296 | ||
| P433 | issue | 12 | |
| P921 | main subject | latanoprost | Q634959 |
| P304 | page(s) | 2702-2712 | |
| P577 | publication date | 2013-08-29 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Latanoprost effectively ameliorates glucose and lipid disorders in db/db and ob/ob mice | |
| P478 | volume | 56 |
| Q36627589 | Anti-diabetic activities of catalpol in db/db mice |
| Q64107729 | Gut Microbiota Composition and Structure of the Ob/Ob and Db/Db Mice |
| Q92128838 | Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice |
| Q45740589 | Tetradecyl 2,3-Dihydroxybenzoate Improves the Symptoms of Diabetic Mice by Modulation of Insulin and Adiponectin Signaling Pathways |
Search more.